|
Volumn 47, Issue 7, 2002, Pages 1530-1537
|
Measuring symptom distress and health-related quality of life in clinical trials of gastroesophageal reflux disease treatment: Further validation of the Gastroesophageal Reflux Disease Symptom Assessment Scale (GSAS)
a a a b b |
Author keywords
Gastroesophageal reflux disease; Health related quality of life; SF 36 Health Survey; Symptom distress
|
Indexed keywords
RABEPRAZOLE;
ADULT;
AGED;
ARTICLE;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DISEASE SEVERITY;
DISTRESS SYNDROME;
DOUBLE BLIND PROCEDURE;
FEMALE;
GASTROESOPHAGEAL REFLUX;
HEALTH SURVEY;
HEARTBURN;
HUMAN;
MAJOR CLINICAL STUDY;
MALE;
NAUSEA;
PAIN ASSESSMENT;
PRIORITY JOURNAL;
QUALITY OF LIFE;
RANDOMIZED CONTROLLED TRIAL;
RATING SCALE;
RELIABILITY;
SATIETY;
SYMPTOM;
VALIDATION PROCESS;
2-PYRIDINYLMETHYLSULFINYLBENZIMIDAZOLES;
ADULT;
BENZIMIDAZOLES;
DOUBLE-BLIND METHOD;
FEMALE;
GASTROESOPHAGEAL REFLUX;
HEALTH STATUS INDICATORS;
HUMANS;
MALE;
MIDDLE AGED;
OMEPRAZOLE;
PROTON PUMPS;
QUALITY OF LIFE;
RANDOMIZED CONTROLLED TRIALS;
SEVERITY OF ILLNESS INDEX;
|
EID: 0036310658
PISSN: 01632116
EISSN: None
Source Type: Journal
DOI: 10.1023/A:1015815102175 Document Type: Article |
Times cited : (48)
|
References (16)
|